We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Bruker
BRKR
$9.2B
| $370K | 0.01% |
+10,780
| New | +$353K |
|
|
FOE
1377
DELISTED
Ferro Corporation
FOE
| $369K | 0.01% |
+15,649
| New | +$370K |
|
1378
Thermo Fisher Scientific
TMO
$211B
| $368K | 0.01% |
1,939
-14,361
| -88% | -$2.75M |
|
1379
Gold Fields
GFI
$29.2B
| $367K | 0.01% |
85,355
-206,486
| -71% | -$833K |
|
|
ATSG
1380
DELISTED
Air Transport Services Group
ATSG
| $367K | 0.01% |
+15,863
| New | +$379K |
|
1381
Okta
OKTA
$24.1B
| $366K | 0.01% |
+14,309
| New | +$400K |
|
|
NPTN
1382
DELISTED
NEOPHOTONICS CORP
NPTN
| $366K | 0.01% |
+55,630
| New | +$340K |
|
1383
AppFolio
APPF
$5.85B
| $365K | 0.01% |
8,790
+4,453
| +103% | +$200K |
|
1384
Kraft Heinz
KHC
$30.4B
| $365K | 0.01% |
4,700
-214,388
| -98% | -$16.8M |
|
|
PVG
1385
DELISTED
PRETIUM RESOURCES INC.
PVG
| $365K | 0.01% |
32,027
+10,259
| +47% | +$112K |
|
|
MB
1386
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $365K | 0.01% |
+12,002
| New | +$369K |
|
|
B
1387
DELISTED
Barnes Group Inc.
B
| $364K | 0.01% |
5,747
-15,471
| -73% | -$1.03M |
|
|
MNTA
1388
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $362K | 0.01% |
25,954
-8,495
| -25% | -$115K |
|
1389
Cohen & Steers Duration Preferred & Income Fund
LDP
$599M
| $361K | 0.01% |
+13,861
| New | +$366K |
|
1390
Madrigal Pharmaceuticals
MDGL
$12.6B
| $360K | 0.01% |
+3,925
| New | +$224K |
|
1391
Protolabs
PRLB
$1.86B
| $359K | 0.01% |
+3,484
| New | +$313K |
|
|
ORIT
1392
DELISTED
Oritani Financial Corp. New
ORIT
| $359K | 0.01% |
+21,901
| New | +$368K |
|
|
ALDR
1393
DELISTED
Alder Biopharmaceuticals
ALDR
| $359K | 0.01% |
+31,358
| New | +$350K |
|
|
ALE
1394
DELISTED
Allete
ALE
| $358K | 0.01% |
4,811
-13,788
| -74% | -$1.07M |
|
1395
TIM SA
TIMB
$10.2B
| $357K | 0.01% |
+18,475
| New | +$342K |
|
|
MNR
1396
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $357K | 0.01% |
20,075
-14,662
| -42% | -$254K |
|
1397
Angi Inc
ANGI
$224M
| $356K | 0.01% |
+3,399
| New | +$394K |
|
1398
Kennametal
KMT
$2.68B
| $356K | 0.01% |
+7,355
| New | +$328K |
|
|
HIMX
1399
Himax Technologies
HIMX
$2.2B
| $354K | 0.01% |
33,994
+13,536
| +66% | +$147K |
|
1400
Western Union
WU
$2.57B
| $354K | 0.01% |
18,627
-15,871
| -46% | -$311K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.